Transgenic mouse model for studying the transcriptional activity of the p53 protein: Age- and tissue-dependent changes in radiation-induced activation during embryogenesis

EMBO Journal

Volumn 16, Issue 6, 1997, Pages 1381-1390

  Gottlieb, Eyal ^a   Haffner, Rebecca ^a   King, Ayala ^a   Asher, Gad ^a   Gruss, Peter ^a   Lonai, Peter ^b   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

Embryogenesis; mdm2; p53; Transcriptional activation; Transgenics

Indexed keywords

PROTEIN P53;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE ACTIVATION; GENE FUSION; GENOTYPE; IONIZING RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION; TRANSGENE;

ALLELES; ANIMALS; BASE SEQUENCE; DNA DAMAGE; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, P53; GENES, REPORTER; GESTATIONAL AGE; HAPLOTYPES; LAC OPERON; MALE; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; PREGNANCY; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TISSUE DISTRIBUTION; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MUS MUSCULUS;

EID: 0030898436     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.6.1381     Document Type: Article

References (61)

1. Armstrong, J.F., Kaufman, M.H., Harrison, D.J. and Clarke, A.R. (1995) High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol., 5, 931-936.
2. Barak, Y., Gottlieb, E., Juven-Gershon, T. and Oren, M. (1994) Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Gene Dev., 8, 1739-1749.
3. Caelles, C., Helmberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-223.
4. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
5. Clarke, A.R., Gledhill, S., Hooper, M.L., Bird, C.C. and Wyllie, A.H. (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene, 9, 1767-1773
6. Donehower, L.A., Harvey, M., Slagle, B.L., Mcarthur, M.J., Montgomery, C.A., Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmental normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
7. Donehower, L.A., Godley, L.A., Aldaz, C.M., Pyle, R., Shi, Y.P., Pinkel, D., Gray, T., Bradley, A., Medina, D. and Varmus, H.E. (1995) Deficiency of p53 accelerates mammary tumorigenesis in wnt-1 transgenic mice and promotes chromosomal instability. Gene Dev., 9, 882-895.
8. Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledge, S.J. and Reed, S.I. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023.
9. El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. and Vogelstein, B. (1992) Definition of a consensus binding site for p53. Nature Genet., 1, 45-49.
10. El-Deiry, W.S. et al. (1995) Topological control of p21(WAF1/CIP1) expression in normal and neoplastic tissues. Cancer Res., 55, 2910-2919.
11. Funk, W.D., Pak, D.T., Karas, R.H., Wright, W.E. and Shay, J.W. (1992) A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol., 12, 2866-2871.
12. Goldhamer, D.J., Brunk, B.P., Faerman, A., King, A., Shani, M. and Emerson, C.P., Jr (1995) Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development, 121, 637-649.
13. Gottlieb, T.M. and Oren, M. (1996) p53 in growth control and neoplasia. Biochim. Biophys. Acta, 1287, 77-102.
14. Gottlieb, E., Lindner, S. and Oren, M. (1996) Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells. Cell Growth Differ., 7, 301-310.
15. Graeber, T.G., Osmanian, C., Jacks, T., Housman, D.E., Koch, C.J., Lowe, S.W. and Giaccia, A.J. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
16. Haffner, R. and Oren, M. (1995) Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev., 5, 84-90.
17. Halevy, O., Novitch, B.G. Spicer, D.B. Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D. and Lassar, A.B. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science, 267, 1018-1021.
18. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H. and Oren, M. (1995) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Gene Dev., 9, 2170-2183.
19. Hogan, B. Beddington, R. Constantini, F. and Lacy, E. (eds) (1994) Manipulating the Mouse Embryo: a Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Hupp, T.R., Sparks, A. and Lane, D.P. (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell, 83, 237-245.
21. Jacks, T. and Weinberg, R.A. (1996) Cell cycle control and its watchman. Nature, 381, 643-644.
22. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R. T. and Weinberg, R.A. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
23. Juven, T., Barak, Y., Zauberman, A., George, D.L. and Oren, M. (1993) Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogen, 8, 3411-3416.
24. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
25. Kastan, M.B., Zhan, Q.M., Eldeiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B. and Fornace, A.J. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
26. Kemp, C.J., Donehower, L.A., Bradley, A. and Balmain, A. (1993) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell, 74, 813-822.
27. Kemp, C.J., Wheldon, T. and Balmain, A. (1994) p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genet., 8, 66-69.
28. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm. Gene. Dev., 10, 1054-1072.
29. Komarova, E.A. et al. (1997) Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation- and drug-sensitivity in vivo. EMBO J., 16, 1391-1400.
30. Lane, D. P. (1991) p53, guardian of the genome. Nature, 358, 15-16.
31. Linke, S.P., Clarkin, K.C . Di Leonardo, A., Tsou, A. and Wahl, G.M. (1996) A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Gene Dev., 10, 934-947.
32. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
33. Lu, X. and Lane, D.P. (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation - defects in chromosome instability syndromes? Cell, 75, 765-778.
34. Lutzker, S.G. and Levine, A.J. (1996) A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nature Med., 2, 804-810.
35. Malkin, D. et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-1238.
36. Merritt, A.J., Potten, C.S., Kemp, C.J., Hickman, J.A., Balmain, A., Lane, D.P. and Hall, P.A. (1994) The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res., 54, 614-617.
37. Michieli, P., Chedid, M., Lin, D., Pierce, J.H., Mercer, W.E. and Givol, D. (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54, 3391-3395.
38. Midgley, C.A., Owens, B., Briscoe, C.V. Thomas, D.B., Lane, D.P. and Hall, P.A. (1995) Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell Sci., 108, 1843-1848.
39. Montes de Oca Luna, R., Wagner, D.S. and Lozano, G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature, 378, 203-206.
40. Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F. and Deppert, W. (1995) Negative feedback regulation of wild-type p53 biosynthesis. EMBO J., 14, 4442-4449.
41. Nicol, C.J., Harrison, M.L., Laposa, R.R., Gimelshtein, I.L. and Wells, P.G. (1995) A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nature Genet., 10, 181-187.
42. Norimura, T., Nomoto, S., Katsuki, M., Gondo, Y. and Kondo, S. (1996) p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nature Med., 2, 577-580.
43. Oren, M., Maltzman, W. and Levine, A.J. (1981) Post-translational regulation of the 54K cellular tumor antigen in norman and transformed cells. Mol. Cell. Biol., 1, 101-110.
44. Oren, M., Reich, N.C. and Levine, A.J. (1982) Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Mol. Cell. Biol., 2, 443-449.
45. Parker, S.B., Eichele, G., Zhang, P.M., Rawls, A., Sands, A.T., Bradley, A., Olson, E.N., Harper, J.W. and Elledge, S.J. (1995) p53-independent expression of p21(Cip)1 in muscle and other terminally differentiating cells. Science, 267, 1024-1027.
46. Pennica, D., Goeddel, D.V., Hayflick, J.S., Reich, N.C., Anderson, C.W. and Levine, A.J. (1984) The amino acid sequence of murine p53 determined from a c-DNA clone. Virology, 134, 477-482.
47. Reich, N.C., Oren, M. and Levine, A.J. (1983) Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol. Cell. Biol., 3, 2143-2150.
48. Rogel, A., Popliker, M., Webb, C.G. and Oren, M. (1985) p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol. Cell. Biol., 5, 2851-2855.
49. Rotter, V., Schwartz, D., Almon, E., Goldfinger, N., Kapon, A., Meshorer, A., Donehower, L.A. and Levine, A.J. (1993) Mice with reduced levels of p53 protein exhibit the testicular Giant-Cell degenerative syndrome. Proc. Natl Acad. Sci. USA, 90, 9075-9079.
50. Rotter, V. et al. (1994) Does wild-type p53 play a role in normal cell differentiation? Semin. Cancer Biol., 5, 229-236.
51. Sah, V.P., Attardi, L.D., Mulligan, G.J., Williams, B.O., Bronson, R.T. and Jacks, T. (1995) A subset of p53-deficient embryos exhibit exencephaly. Nature Genet., 10, 175-180.
52. Schmid, P. Lorenz, A., Hameister, H. and Montenarh, M. (1991) Expression of p53 during mouse embryogenesis. Development, 113, 857-865.
53. Stenger, J.E., Tegtmeyer, P., Mayr, G.A., Reed, M., Wang, Y., Wang, P., Hough, P.V. and Mastrangelo, I.A. (1994) p53 oligomerization and DNA looping are linked with transcriptional activation. EMBO J., 13, 6011-6020.
54. Tanaka, N., Ishihara, M., Lamphier, M.S., Nozawa, H., Matsuyama, T., Mak, T.W., Tokino, T., Oren, M. and Taniguchi, T. (1996) Cooperation of two tumor suppressor, IRF-1 and p53, in response to DNA damage. Nature, 382, 816-818.
55. Timme, T.L. and Thompson, T.C. (1994) Rapid allelotype analysis of p53 knockout mice. Biotechniques, 17, 460-463.
56. Wu, X.W., Bayle, J.H., Olson, D. and Levine, A.J. (1993) The p53 mdm-2 autoregulatory feedback loop. Gene Dev., 7, 1126-1132.
57. Wubah, J.A., Ibrahim, M.M., Gao, X., Nguyen, D., Pisano, M.M. and Knudsen, T.B. (1996) Teratogen-induced eye defects mediated by p53-dependent apoptosis. Curr. Biol., 6, 60-69.
58. Zauberman, A., Lupo, A. and Oren, M. (1995) Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites. Oncogene, 10, 2361-2366.
59. Zhan, Q.M., Carrier, F. and Fornace, A.J. (1993) Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol., 13, 4242-4250.
60. Zhan, Q.M., Fan, S.J., Bae, I., Guillouf, C., Liebermann, D.A., Oconnor, P.M. and Fornace, A.J. (1994) Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene, 9, 3743-3751.
61. Zhang, W., Grasso, L., McClain, C.D., Gambel, A.M., Cha, Y., Travali, S., Deisseroth, A.B. and Mercer, W.E. (1995) p53-independent induction of WAF1/C1P1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55, 668-674.